Default Hero Image

Karen Blindauer, MD

karenblindauer

Karen Ann Blindauer, MD

Professor of Neurology; Adult Division Chief; Director, Movement Disorders Program

Locations

  • Medical College of Wisconsin
    Department of Neurology

Contact Information

Biography

Internal Medicine Internship, Medical College of Wisconsin, Milwaukee, WI, 1993 - 1994
Neurology Residency, Medical College of Wisconsin, Milwaukee, WI, 1994 - 1997
Movement Disorders and Experimental Therapeutics Fellowship, University of Rochester, Rochester, NY, 1997 - 1999

Societies

American Academy of Neurology
American Medical Association
Movement Disorders Society

Honors and Awards

Delta Sigma Nu Scholastic Honor Society, 1988
Scott Foundation Scholarship, 1989
Cornelius G. Dyke Award for Excellence in Neurology, 1993
David Fine MD Award for Excellence in Post Graduate Training, 1997
Alpha Omega Alpha Medical Honor Society, 1993
Dystonia Medical Research Foundation, Dystonia Doctor of Excellence Award, 2000
Selected for inclusion in Best Doctors of America

Education

MD, Medical College of Wisconsin, Milwaukee, WI, 1993

Publications

  • Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial.

    (Huntington Study Group, Frank S, Testa CM, Stamler D, Kayson E, Davis C, Edmondson MC, Kinel S, Leavitt B, Oakes D, O'Neill C, Vaughan C, Goldstein J, Herzog M, Snively V, Whaley J, Wong C, Suter G, Jankovic J, Jimenez-Shahed J, Hunter C, Claassen DO, Roman OC, Sung V, Smith J, Janicki S, Clouse R, Saint-Hilaire M, Hohler A, Turpin D, James RC, Rodriguez R, Rizer K, Anderson KE, Heller H, Carlson A, Criswell S, Racette BA, Revilla FJ, Nucifora F Jr, Margolis RL, Ong M, Mendis T, Mendis N, Singer C, Quesada M, Paulsen JS, Brashers-Krug T, Miller A, Kerr J, Dubinsky RM, Gray C, Factor SA, Sperin E, Molho E, Eglow M, Evans S, Kumar R, Reeves C, Samii A, Chouinard S, Beland M, Scott BL, Hickey PT, Esmail S, Fung WL, Gibbons C, Qi L, Colcher A, Hackmyer C, McGarry A, Klos K, Gudesblatt M, Fafard L, Graffitti L, Schneider DP, Dhall R, Wojcieszek JM, LaFaver K, Duker A, Neefus E, Wilson-Perez H, Shprecher D, Wall P, Blindauer KA, Wheeler L, Boyd JT, Houston E, Farbman ES, Agarwal P, Eberly SW, Watts A, Tariot PN, Feigin A, Evans S, Beck C, Orme C, Edicola J, Christopher E.) JAMA. 2016 Jul 05;316(1):40-50.

  • A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.

    (Parkinson Study Group QE3 Investigators, Beal MF, Oakes D, Shoulson I, Henchcliffe C, Galpern WR, Haas R, Juncos JL, Nutt JG, Voss TS, Ravina B, Shults CM, Helles K, Snively V, Lew MF, Griebner B, Watts A, Gao S, Pourcher E, Bond L, Kompoliti K, Agarwal P, Sia C, Jog M, Cole L, Sultana M, Kurlan R, Richard I, Deeley C, Waters CH, Figueroa A, Arkun A, Brodsky M, Ondo WG, Hunter CB, Jimenez-Shahed J, Palao A, Miyasaki JM, So J, Tetrud J, Reys L, Smith K, Singer C, Blenke A, Russell DS, Cotto C, Friedman JH, Lannon M, Zhang L, Drasby E, Kumar R, Subramanian T, Ford DS, Grimes DA, Cote D, Conway J, Siderowf AD, Evatt ML, Sommerfeld B, Lieberman AN, Okun MS, Rodriguez RL, Merritt S, Swartz CL, Martin WR, King P, Stover N, Guthrie S, Watts RL, Ahmed A, Fernandez HH, Winters A, Mari Z, Dawson TM, Dunlop B, Feigin AS, Shannon B, Nirenberg MJ, Ogg M, Ellias SA, Thomas CA, Frei K, Bodis-Wollner I, Glazman S, Mayer T, Hauser RA, Pahwa R, Langhammer A, Ranawaya R, Derwent L, Sethi KD, Farrow B, Prakash R, Litvan I, Robinson A, Sahay A, Gartner M, Hinson VK, Markind S, Pelikan M, Perlmutter JS, Hartlein J, Molho E, Evans S, Adler CH, Duffy A, Lind M, Elmer L, Davis K, Spears J, Wilson S, Leehey MA, Hermanowicz N, Niswonger S, Shill HA, Obradov S, Rajput A, Cowper M, Lessig S, Song D, Fontaine D, Zadikoff C, Williams K, Blindauer KA, Bergholte J, Propsom CS, Stacy MA, Field J, Mihaila D, Chilton M, Uc EY, Sieren J, Simon DK, Kraics L, Silver A, Boyd JT, Hamill RW, Ingvoldstad C, Young J, Thomas K, Kostyk SK, Wojcieszek J, Pfeiffer RF, Panisset M, Beland M, Reich SG, Cines M, Zappala N, Rivest J, Zweig R, Lumina LP, Hilliard CL, Grill S, Kellermann M, Tuite P, Rolandelli S, Kang UJ, Young J, Rao J, Cook MM, Severt L, Boyar K.) JAMA Neurol. 2014 May;71(5):543-52.

  • Neural basis for impaired time reproduction in Parkinson's disease: an fMRI study.

    (Elsinger CL, Rao SM, Zimbelman JL, Reynolds NC, Blindauer KA, Hoffmann RG.) J Int Neuropsychol Soc. 2003 Nov;9(7):1088-98.

  • Incidence of dominant spinocerebellar and Friedreich triplet repeats among 361 ataxia families.

    (Moseley ML, Benzow KA, Schut LJ, Bird TD, Gomez CM, Barkhaus PE, Blindauer KA, Labuda M, Pandolfo M, Koob MD, Ranum LP.) Neurology. 1998 Dec;51(6):1666-71.

  • Single-voxel proton MR spectroscopy of nonneoplastic brain lesions suggestive of a neoplasm.

    (Krouwer HG, Kim TA, Rand SD, Prost RW, Haughton VM, Ho KC, Jaradeh SS, Meyer GA, Blindauer KA, Cusick JF, Morris GL, Walsh PR.) AJNR Am J Neuroradiol. 1998 Oct;19(9):1695-703.

  • Fulminant progression of demyelinating disease after valproate-induced encephalopathy.

    (Blindauer KA, Harrington G, Morris GL 3rd, Ho KC.) Neurology. 1998 Jul;51(1):292-5.